The Effect of the Tumor Microenvironment and Tumor-Derived Metabolites on Dendritic Cell Function

被引:32
|
作者
Lee, Jun-Ho [1 ,2 ]
Choi, So-Yeon [1 ]
Jung, Nam-Chul [2 ]
Song, Jie-Young [3 ]
Seo, Han Geuk [4 ]
Lee, Hyun Soo [2 ]
Lim, Dae-Seog [1 ]
机构
[1] CHA Univ, Dept Biotechnol, 335 Pangyo Ro, Seongnam 13488, Gyeonggi Do, South Korea
[2] Pharos Vaccine Inc, 545 Dunchon Daero, Seongnam 13215, Gyeonggi Do, South Korea
[3] Korea Inst Radiol & Med Sci, Dept Radiat Canc Sci, 75 Nowon Ro, Seoul 01812, South Korea
[4] Konkuk Univ, Sanghuh Coll Life Sci, Dept Food Sci & Biotechnol Anim Prod, 120 Neungdong Ro, Seoul 05029, South Korea
来源
JOURNAL OF CANCER | 2020年 / 11卷 / 04期
基金
新加坡国家研究基金会;
关键词
dendritic cells; tumor microenvironment; exogenous factor; metabolite; HUMAN SERUM-ALBUMIN; CANCER-IMMUNOTHERAPY; EPITHELIAL-CELLS; T-CELLS; DYSFUNCTION; GENERATION; CD39; CD73; EXPRESSION; VACCINES;
D O I
10.7150/jca.38785
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Dendritic cells (DCs) have a critical effect on the outcome of adaptive immune responses against growing tumors. Recent studies on the metabolism on DCs provide new insights on the functioning of these critical controllers of innate and adaptive immunity. DCs within the tumor microenvironment (TME) often exist in an inactive state, which is thought to limit the adaptive immune response elicited by the growing tumor. Tumor-derived factors in the TME are known to suppress DC activation and result in functional alterations in DC phenotype. We are now beginning to appreciate that many of these factors can also induce changes in immune cell metabolism. In this review, we discuss the functional alternation of DC phenotype by tumor metabolites.
引用
收藏
页码:769 / 775
页数:7
相关论文
共 50 条
  • [1] Tumor-derived factors modulating dendritic cell function
    Zong, Jinbao
    Keskinov, Anton A.
    Shurin, Galina V.
    Shurin, Michael R.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2016, 65 (07) : 821 - 833
  • [2] Tumor-derived factors modulating dendritic cell function
    Jinbao Zong
    Anton A. Keskinov
    Galina V. Shurin
    Michael R. Shurin
    Cancer Immunology, Immunotherapy, 2016, 65 : 821 - 833
  • [3] Emerging role of tumor-derived extracellular vesicles in T cell suppression and dysfunction in the tumor microenvironment
    Ma, Feiya
    Vayalil, Jensen
    Lee, Grace
    Wang, Yuqi
    Peng, Guangyong
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (10)
  • [4] Tumor-derived extracellular vesicles: Regulators of tumor microenvironment and the enlightenment in tumor therapy
    Chen, Jiming
    Fei, Xuefeng
    Wang, Jianli
    Cai, Zhijian
    PHARMACOLOGICAL RESEARCH, 2020, 159
  • [5] Tumor-derived exosomes in the cancer immune microenvironment and cancer immunotherapy
    Tang, Qiushi
    Yang, Shuo
    He, Guangpeng
    Zheng, Hongyu
    Zhang, Sheng
    Liu, Jiaxing
    Wei, Shibo
    Fan, Qing
    Peng, Xueqiang
    Li, Xinyu
    Zhang, Dewei
    Yang, Liang
    Li, Hangyu
    CANCER LETTERS, 2022, 548
  • [6] New roles of tumor-derived exosomes in tumor microenvironment
    Chen, Shiqian
    Sun, Jinzhe
    Zhou, Huan
    Lei, Hongbin
    Zang, Dan
    Chen, Jun
    CHINESE JOURNAL OF CANCER RESEARCH, 2024, 36 (02)
  • [7] Metabolic gatekeepers: harnessing tumor-derived metabolites to optimize T cell-based immunotherapy efficacy in the tumor microenvironment
    Zheng, Yucheng
    Xu, Rongwei
    Chen, Xu
    Lu, Ye
    Zheng, Jiarong
    Lin, Yunfan
    Lin, Pei
    Zhao, Xinyuan
    Cui, Li
    CELL DEATH & DISEASE, 2024, 15 (10):
  • [8] Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment
    Tian, Xinyu
    Shen, Han
    Li, Zhiyang
    Wang, Tingting
    Wang, Shengjun
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (01)
  • [9] Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment
    Xinyu Tian
    Han Shen
    Zhiyang Li
    Tingting Wang
    Shengjun Wang
    Journal of Hematology & Oncology, 12
  • [10] The Effect of Tumor-derived Arginase on T Cell Suppression and Tumor Progression
    Palen, Katie A.
    Phillips, Aaron A.
    Johnson, Bryon D.
    Gershan, Jill A.
    JOURNAL OF IMMUNOTHERAPY, 2012, 35 (09) : 785 - 786